Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages
- 29 March 2008
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 87 (4) , 339-350
Abstract
We generated red blood cells (RBC) from cord blood (CB) CD34+ cells using a four-phase culture system. We first cultured CB CD34+ cells on telomerase gene-transduced human stromal cells in serum-free medium containing stem cell factor (SCF), Flt-3/Flk-2 ligand, and thrombopoietin to expand CD34+ cells (980-fold) and the total cells (10,400-fold) (first phase). Expanded cells from the first phase were liquid-cultured with SCF, interleukin-3 (IL-3), and erythropoietin (EPO) to expand (113-fold) and differentiate them into erythroblasts (second phase). To obtain macrophages for the next phase, we expanded CD34+ cells from a different donor using the same co-culture system. Expanded cells from the first phase were liquid-cultured with granulocyte-macrophage colony stimulating factor, macrophage-colony stimulating factor (M-CSF), IL-3, and SCF to generate monocytes/macrophages (75-fold), which were incubated with type AB serum and M-CSF to fully differentiate them into macrophages. Erythroblasts were then co-cultured with macrophages in the presence of EPO to expand (threefold) and fully differentiate them (61% orthochromatic erythroblasts plus 39% RBC) (third phase). RBC were purified from erythroblasts and debris through a deleukocyting filter to generate 6.0 × 1012 RBC from 1.0 unit of CB (3.0 transfusable units). Qualitatively, these RBC showed a hemoglobin content, oxygenation of hemoglobin, and in vivo clearance similar to those of adult peripheral RBC. Finally, an almost complete enucleation of orthochromatic erythroblasts (99.4%) was achieved by the cultivation method recently described by Miharada et al. in the absence of macrophages and cytokines (fourth phase). RBC were purified from remnant erythroblasts and debris by passage through a deleukocyting filter to generate 1.76 × 1013 RBC from 1.0 unit of CB (8.8 transfusable units), the highest yield ever reported. Thus, this method may be useful for generating an alternative RBC supply for transfusions, investigating infectious agents that target erythroid cells, and as a general in vitro hematopoietic model system.Keywords
This publication has 38 references indexed in Scilit:
- Ex Vivo Large‐Scale Generation of Human Platelets from Cord Blood CD34 + CellsStem Cells, 2006
- Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cellsNature Biotechnology, 2006
- Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formationBlood, 2006
- Feline Babesiosis in South Africa: A ReviewAnnals of the New York Academy of Sciences, 2004
- Novel secreted isoform of adhesion molecule ICAM-4: potential regulator of membrane-associated ICAM-4 interactionsBlood, 2003
- Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivoNature Biotechnology, 2002
- Identification of a factor that links apoptotic cells to phagocytesNature, 2002
- Requirement of DNase II for Definitive Erythropoiesis in the Mouse Fetal LiverScience, 2001
- A receptor for phosphatidylserine-specific clearance of apoptotic cellsNature, 2000
- Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptorJournal of Clinical Investigation, 2000